Experience with insulin detemir for type 2 diabetes in older people and people with comorbidities
Detemir appears to be an effective and well-tolerated treatment for T2D in older people, and those with CVD, renal disease or liver disease.
Authors
- Uffe Christian Braae (ORCID: https://orcid.org/0000-0002-2743-4584)
- Amra Ciric Alibegovic
- Anders Boeck Jensen (ORCID: https://orcid.org/0000-0002-5784-308X)
- Melanie Jane Davies (ORCID: https://orcid.org/0000-0002-9987-9371)
- Renuka Munikrishnappa
Institutions
- Novo Nordisk (Denmark) (DK)
- Leicester General Hospital (GB)
- Novo Nordisk (India) (IN)
Publication Details
- Journal
- Diabetes & Metabolic Syndrome Clinical Research & Reviews
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.dsx.2025.103327
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29